predominantly protein structure plays a significant
role during phage display. During lysis, the cyclic
DNA knows the synthesis of proteins required for
viral replication, phage particle assembly, and cell
lysis.
The advantage is that in the lysed state, the phage
integrates itself into the chromosome of the host cell
via lysogen and its lambda DNA resides in the host's
genome without causing significant harm to the host.
However, intracellular activity in the host cell is not
easily monitored.
2.5 Current Use for Locating Targets
Phage presentation technology can be well combined
with Chinese medicine into an effective target
screening tool for drugs. It can present exogenous
proteins and peptides on the phage surface and utilize
the specific affinity interaction of exogenous proteins
and peptides with the unknown to be screened. And
the phages that fail to bind will be discarded.
Afterward, the bound phages are eluted with reagents,
the eluted phages are collected and infected with
bacteria for amplification, and the resulting phages
are then repeated for the screening process. In this
way, after 3-5 rounds of "adsorption-elution-
amplification" cycle screening, phages that
specifically bind to the treated phage exogenous
peptide can be found. After gene sequence analysis,
the corresponding basic amino acid sequences, which
bind specifically to the target molecule, are obtained
based on the sequencing results. The proteins in the
organism containing the above amino acid sequences
are analyzed with the help of bioinformatics to obtain
the corresponding target proteins in the organism
(Feng 2021).
The advantage of this technique is that the phage
is easy to amplify and select, and the protein or
peptide obtained after screening can also be
determined by determining the DNA sequence of the
insert. Rodi (Rodi 1999) applied this method to
screen a random library of phage display peptides and
the binding of biotinylated derivatives of paclitaxel
(Taxol). The binding of paclitaxel to the anti-
apoptotic human protein Bcl-2 was confirmed by
ELISA assay. Zhang (Zhang 2017) studied that the
phage library of 15 peptide random sequences was
used to screen for specific cellular targets of
strychnine, interacting with cell-selective binding
peptides to investigate the mechanism of antitumor
activity of strychnine. Sun (Sun 2016) analyzed that
the specificity and molecular interactions between the
candidate binding protein Ubiquinol-cytochrome c
reductase binding protein (UQCRB) and oxymatrine
were investigated using the T7 phage technique. The
interaction between the two demonstrated that
UQCRB is a potential target for the treatment of
chronic hepatitis B (CHB).
3 CONCLUSION
Nowadays, TCM has triggered the research of many
scientists and there are many methods available to
determine the targets and active ingredients of TCM.
Each herbal medicine has its own composition and
validation methods. In the paper, a summarization of
the pros and cons of several common methods and
use cases would provide references for further
analysis. Considering the complexity and diversity of
the components and targets of TCM, it is difficult for
a single method to effectively analyze get an accurate
determination. The combination and practice of
multiple methods can better achieve the desired
results and can also improve the efficiency and
accuracy of the purpose.
REFERENCES
Bullitt (1990). “Expression of c-fos-like protein as a marker
for neuronal activity following noxious stimulation in
the rat. J Comp Neurol.
Cruz et al. (2015). “Using c-fos to study neuronal
ensembles in corticostriatal circuitry of addiction. Brain
Res. 1628.
Fan Lin, Zongming Chen; Standardization of Diagnostic
Immunohistochemistry: Literature Review and
Geisinger Experience. Arch Pathol Lab Med 1
December 2014; 138 (12): 1564–1577. doi:
https://doi.org/10.5858/arpa.2014-0074-RA
Fei B, Dai W, Zhao S. Efficacy, Safety, and Cost of
Therapy of the Traditional Chinese Medicine, Catalpol,
in Patients Following Surgical Resection for Locally
Advanced Colon Cancer. Med Sci Monit. 2018 May
15; 24: 3184-3192. doi: 10.12659/MSM.907569.
PMID: 29763415; PMCID: PMC5975072.
Feng Lu, Dan Wang, Ruo-Lan Li, Li-Ying He, Li Ai, Chun-
Jie Wu. Current strategies and technologies for finding
drug targets of active components from traditional
Chinese medicine. Frontiers in Bioscience-Landmark.
2021. 26(9); 572-589.
Forum on Neuroscience and Nervous System Disorders;
Board on Health Sciences Policy; Institute of Medicine.
Improving and Accelerating Therapeutic Development
for Nervous System Disorders: Workshop Summary.
Washington (DC): National Academies Press (US);
2014 Feb 6. 2, Drug Development Challenges.
Available from:
https://www.ncbi.nlm.nih.gov/books/NBK195047